CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING: EXPLORING THE GAP BETWEEN PATIENT AND PROVIDER PERCEPTIONS OF CARE

2.50
Hdl Handle:
http://hdl.handle.net/10755/164613
Category:
Abstract
Type:
Presentation
Title:
CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING: EXPLORING THE GAP BETWEEN PATIENT AND PROVIDER PERCEPTIONS OF CARE
Author(s):
Rogers, Miriam; Salsman, John; Beaumont, Jen; Noonan, Jessica; Cella, Dave
Author Details:
Miriam Rogers, EdD, RN, AOCN, CNS, Exec, Director Adult Acute Care/APN Oncology, WakeMed Health and Hospitals, Raleigh, North Carolina, USA, email: mrogers@canursing.com; John Salsman, PhD; Jen Beaumont, MS; Sarah Rosenbloom, PhD; Jessica Noonan, BA; Dave Cella, PhD; Ctr. on Outcomes, Research, & Educ., NorthShore U. HealthSystem, Evanston, IL
Abstract:
Research Study: Despite progress in symptom control, chemotherapy-induced nausea and vomiting (CINV) continues to be problematic, especially in delayed presentation. Grunberg et al. discovered an underestimation of incidence of delayed CINV by treatment providers and gaps in perception between providers and patients. Understanding the frequency and severity of acute and delayed CINV as well as communication about CINV between providers and patients has the potential to help improve outcomes. The purpose of this study is to identify patients' and providers' perceptions of communication, management, and barriers to quality care of CINV, and to explore possible solutions to these barriers. Communication barriers between patients and providers regarding CINV management were identified through literature review and expert input. We then developed patient and provider versions of a Nausea and Vomiting Management Barriers Questionnaire (NVMBQ). The NVMBQ contains likert-scale items addressing potential barriers such as desire to limit medications, lack of provider-initiated communication, and desire to be a "good" patient. Other potential barriers explored include drug access (i.e., formulary), cost, and insurance coverage. Providers and patients are also given opportunities to add detail in openended questions. 300 patient surveys are being administered via the internet through a consortium of advocacy groups. Patients with a current or past history of breast, colon or lung cancers, leukemia or lymphoma are eligible. 150 provider surveys are also being administered via the Internet. 75 oncologists will be recruited through the National Comprehensive Cancer Network and 75 oncology nurses will be recruited through Oncology Nursing Society mailing lists. All participants will complete a sociodemographic form and their respective NVMBQ. Descriptive statistics (N, percent) will be tabulated for responses to each of the survey questions for the patient and provider samples and compared. Chi-square tests will be used to evaluate whether patient characteristics (e.g. diagnosis groups) or provider backgrounds predict item ratings. Open-ended responses will be summarized and frequency tabulation used to identify aggregate theme. Data collection is underway. Collection and analysis will be completed by April 2009. Findings will inform subsequent qualitative research and guide potential interventions.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2009
Conference Name:
34th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
San Antonio, Texas, USA
Sponsors:
Funding Source: GlaxoSmithKline
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleCHEMOTHERAPY-INDUCED NAUSEA AND VOMITING: EXPLORING THE GAP BETWEEN PATIENT AND PROVIDER PERCEPTIONS OF CAREen_GB
dc.contributor.authorRogers, Miriamen_US
dc.contributor.authorSalsman, Johnen_US
dc.contributor.authorBeaumont, Jenen_US
dc.contributor.authorNoonan, Jessicaen_US
dc.contributor.authorCella, Daveen_US
dc.author.detailsMiriam Rogers, EdD, RN, AOCN, CNS, Exec, Director Adult Acute Care/APN Oncology, WakeMed Health and Hospitals, Raleigh, North Carolina, USA, email: mrogers@canursing.com; John Salsman, PhD; Jen Beaumont, MS; Sarah Rosenbloom, PhD; Jessica Noonan, BA; Dave Cella, PhD; Ctr. on Outcomes, Research, & Educ., NorthShore U. HealthSystem, Evanston, ILen_US
dc.identifier.urihttp://hdl.handle.net/10755/164613-
dc.description.abstractResearch Study: Despite progress in symptom control, chemotherapy-induced nausea and vomiting (CINV) continues to be problematic, especially in delayed presentation. Grunberg et al. discovered an underestimation of incidence of delayed CINV by treatment providers and gaps in perception between providers and patients. Understanding the frequency and severity of acute and delayed CINV as well as communication about CINV between providers and patients has the potential to help improve outcomes. The purpose of this study is to identify patients' and providers' perceptions of communication, management, and barriers to quality care of CINV, and to explore possible solutions to these barriers. Communication barriers between patients and providers regarding CINV management were identified through literature review and expert input. We then developed patient and provider versions of a Nausea and Vomiting Management Barriers Questionnaire (NVMBQ). The NVMBQ contains likert-scale items addressing potential barriers such as desire to limit medications, lack of provider-initiated communication, and desire to be a "good" patient. Other potential barriers explored include drug access (i.e., formulary), cost, and insurance coverage. Providers and patients are also given opportunities to add detail in openended questions. 300 patient surveys are being administered via the internet through a consortium of advocacy groups. Patients with a current or past history of breast, colon or lung cancers, leukemia or lymphoma are eligible. 150 provider surveys are also being administered via the Internet. 75 oncologists will be recruited through the National Comprehensive Cancer Network and 75 oncology nurses will be recruited through Oncology Nursing Society mailing lists. All participants will complete a sociodemographic form and their respective NVMBQ. Descriptive statistics (N, percent) will be tabulated for responses to each of the survey questions for the patient and provider samples and compared. Chi-square tests will be used to evaluate whether patient characteristics (e.g. diagnosis groups) or provider backgrounds predict item ratings. Open-ended responses will be summarized and frequency tabulation used to identify aggregate theme. Data collection is underway. Collection and analysis will be completed by April 2009. Findings will inform subsequent qualitative research and guide potential interventions.en_GB
dc.date.available2011-10-27T12:03:52Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:03:52Z-
dc.conference.date2009en_US
dc.conference.name34th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationSan Antonio, Texas, USAen_US
dc.description.sponsorshipFunding Source: GlaxoSmithKline-
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.